HemaSphere (Aug 2023)
PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
- Turab Mohammed,
- Moazzam Shahzad,
- Lauren Peres,
- Sushmita Khadka,
- Christelle Colinleitzinger,
- Abida Babu,
- William Doyle,
- Omar Castaneda Puglianini,
- Laura Oswald,
- Gabe De Avila,
- Ariel Grajales-Cruz,
- Brandon Blue,
- Jose Ochoa-Bayona,
- Eric Smith,
- Salvatore Corallo,
- Farhad Khimani4,
- Rawan Faramand,
- Hany Elmariah,
- Aleksandr Lazaryan,
- Michael Jain,
- Hien Liu,
- Taiga Nishihori,
- Ken Shain,
- Rachid Baz,
- Melissa Alsina,
- Frederick Locke,
- Ciara Freeman,
- Doris Hansen
Affiliations
- Turab Mohammed
- 1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States
- Moazzam Shahzad
- 1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States
- Lauren Peres
- 2 Moffitt Cancer Center and Research Institute, Department of Cancer Epidemiology, Tampa, United States
- Sushmita Khadka
- 1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States
- Christelle Colinleitzinger
- 2 Moffitt Cancer Center and Research Institute, Department of Cancer Epidemiology, Tampa, United States
- Abida Babu
- 3 USF Health Morsani College of Medicine, Tampa, United States
- William Doyle
- 3 USF Health Morsani College of Medicine, Tampa, United States
- Omar Castaneda Puglianini
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Laura Oswald
- 5 Moffitt Cancer Center and Research Institute, Department of Health Outcomes and Behavior, Tampa, United States
- Gabe De Avila
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Ariel Grajales-Cruz
- 6 Moffitt Cancer Center and Research Institute, Hematology, Myeloma Division, Tampa, United States
- Brandon Blue
- 6 Moffitt Cancer Center and Research Institute, Hematology, Myeloma Division, Tampa, United States
- Jose Ochoa-Bayona
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Eric Smith
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Salvatore Corallo
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Farhad Khimani4
- 1 Moffitt Cancer Center and Research Institute, Hematology - Oncology, Tampa, United States
- Rawan Faramand
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Hany Elmariah
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Aleksandr Lazaryan
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Michael Jain
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Hien Liu
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Taiga Nishihori
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Ken Shain
- 6 Moffitt Cancer Center and Research Institute, Hematology, Myeloma Division, Tampa, United States
- Rachid Baz
- 7 Moffitt Cancer Center and Research Institute, Hematology, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Melissa Alsina
- 7 Moffitt Cancer Center and Research Institute, Hematology, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Frederick Locke
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Ciara Freeman
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- Doris Hansen
- 4 Moffitt Cancer Center and Research Institute, Bone Marrow Transplant and Cellular Immunotherapy Program (BMT - CI), Tampa, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000975160.46377.e2
- Journal volume & issue
-
Vol. 7
p. e46377e2
Abstract
No abstracts available.
